News | June 08, 2022
IOL Chemicals and Pharmaceuticals Q4 FY2022 PAT drops to Rs. 27.75 Cr
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
India is at a key inflexion point of not just ‘Heal in India’ through its vibrant medical value tourism, but also ‘Heal by India’, where our medical professionals can be used to serve not just our country but at the global level.
Subscribe To Our Newsletter & Stay Updated
